Stock ITRM ITERUM THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Iterum Therapeutics plc

Equities

ITRM

IE000TTOOBX0

Delayed Nasdaq
Other stock markets
 12:38:52 2024-05-07 pm EDT 		5-day change 1st Jan Change
1.59 USD 0.00% Intraday chart for Iterum Therapeutics plc +3.92% -19.29%
Apr. 29 Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem CI
Mar. 28 Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Iterum Therapeutics plc Announces the Resignation of Mark Chin as Director, Effective December 31, 2023
CI
Iterum Therapeutics plc Appoints Sailaja Puttagunta as Chief Medical Officer
CI
Iterum Therapeutics plc Announces Resignation of Shahzad Malik from the Board of Directors
CI
Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
CI
Iterum Therapeutics plc Announces Executive Changes
CI
Iterum Therapeutics plc Announces Resignation of James I. Healy as Member of the Board of Directors
CI
Iterum Therapeutics plc Announces Paul R. Edick Term Will Expire At the AGM
CI
Iterum Therapeutics Limited Appoints Jeff Schaffnit as Chief Commercial Officer
CI
Iterum Therapeutics Ltd. Announces Board Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ITRM Stock
  4. News Iterum Therapeutics plc
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW